Opinion: What to expect from ‘Modernizing the FDA’s Data Strategy’ meeting
After being called off because of the Covid-19 pandemic, the FDA’s public meeting to discuss data strategy, an issue that is vital to the future of health care in the United States, is being held — virtually, of course — on Tuesday, June 30.
Like many regulatory bodies, the FDA innovates at a far slower pace than the private sector. This lag time has made it difficult for the FDA to develop a technology strategy that remains relevant from inception of a new drug to deployment.
Read Original Article: Opinion: What to expect from ‘Modernizing the FDA’s Data Strategy’ meeting »
